Navigation Links
The Quantum Group Announces Increased Patient Enrollment Following Medicare Advantage Open Enrollment Period
Date:4/3/2008

Announces business plans for patient recruitment for the balance of the

year

WELLINGTON, Fla., April 3, 2008 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (Amex: QGP, QGP.WSA, QGP.WSB) (http://www.QuantumMD.com) announced today that, following an open enrollment period instituted by The Centers for Medicare and Medicaid Services (CMS), the Company's subsidiary, Renaissance Health Systems, increased its enrolled Medicare Advantage base to 2,240 and is on track to reach a projected 5,000 enrollments by December 31, 2008.

During the CMS open enrollment period, which runs from November 15th through March 31st of each year, Medicare-eligible patients are allowed to choose or switch health plans. Patients who come of eligible age for Medicare or Medicaid during the balance of the year as well as those who become eligible to receive both Medicaid and Medicare benefits or are eligible for special needs waivers, are able to select a plan year round.

Noel J. Guillama, President and CEO of The Quantum Group, stated earlier this week that the Company plans to continue recruitment of Medicare eligible individuals for the remainder of the year. Mr. Guillama said, "The state of Florida welcomes new residents by the thousands each month, many of which are Medicare-eligible and looking to retire in the Sunshine State. We will continue to work with our HMO partners to pursue marketing initiatives geared to the newly Medicare eligible, those who are receiving both Medicare and Medicaid benefits as well as those with special needs waivers."

Guillama continued, "We are also in discussions with our HMO partners to cultivate new or transferred providers and/or patient assignments who are already enrolled in Medicare Advantage plans with each respective HMO.

"Our strategy is on track to focus on the continued growth of our provider base and enhancement of our relationships with our HMO partners during the closed enrollment season. Further, we look forward to the anticipated rollout of several of our most exciting outsourcing services and products geared to increase the efficiency and effectiveness of healthcare providers later this year - particularly our previously announced dynamic technology platform initiative."

Referring to the continued expansion of affiliated healthcare providers, Barbara Roqueta, Senior Vice President of Provider Operations, stated, "We have enjoyed the ongoing growth of our provider base. We are on track to reach our projected goal of 2,500 providers by the end of this calendar year. We have established Community Health Systems in 26 counties and are engaged in an expansion to establish our presence in an additional six counties this calendar year."

About The Quantum Group, Inc.

The Quantum Group is a Florida-based organization that builds and manages healthcare systems and offers consulting and outsourcing services to the nation's largest and fastest growing industry - healthcare.

The Company is leveraging leading-edge technology with the development and execution of a series of innovative patent-pending technology initiatives designed to make Quantum one of the state's leading providers of business solutions for the healthcare industry. Through its growing number of over 1,800 contracted healthcare providers and managed care relationships in the state of Florida, the Company believes it is positioned to bring increased efficiencies to the Florida healthcare industry.

Certain statements contained in this news release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K filings (and amendments thereto) that may cause actual results to materially differ from projections. Forward-looking statements can be identified by the use of words such as "expects," "plans," "will," "may," "anticipates," "believes," "should," "intends," "estimates" and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements. Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to attract and retain executive, management and operational personnel, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well physician clients. The Company does not undertake any obligation to publicly update any forward-looking statements. There can be no assurance that the provisional patents discussed in this press release will be granted by the US Patent and Trademark Office, or, if they are granted, they will not be challenged by third parties, or if not that we will be able to effectively use or commercialize such patents and/or we may not have the resources to deploy such technology. As a result, investors should not place undue reliance on these forward-looking statements.

FOR MORE INFORMATION, PLEASE CONTACT:

BPC Financial Marketing

John Baldissera

800.368.1217

Or

Danielle Amodio

Vice President Corporate Communications

The Quantum Group, Inc.

561.798.9800


'/>"/>
SOURCE The Quantum Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Quantum Group Extends CEOs Employment Agreement
2. The Quantum Group Announces 1st Quarter Financial Results for Fiscal Year 2008
3. The Quantum Group Announces Strategic Technology Alliance
4. The Quantum Group to Present at the Jesup & Lamont Emerging Growth Stock Conference on February 28th
5. The Quantum Group Reports 4th Quarter and Year End Results for Fiscal Year 2007
6. The Quantum Group, Inc. Announces Separation of Units
7. Results promising for computational quantum chemical methods for drug development
8. The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol QGP
9. American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.
10. Quantum Foundation Makes a Half Million Dollars Available to Federally Qualified Health Centers
11. Quantum light beams good for fast technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 2017 , ... ProRehab Physical Therapy (PRPT) is ... therapy provider for Derby City CrossFit, effective immediately. , In addition to treating ... effectively as possible, ProRehab’s sports physical therapists will work with athletes to maximize ...
(Date:4/25/2017)... ... 2017 , ... A recent report from the Wisconsin Institute ... 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools participating ... student test score performance, the report’s limited analyses fail to provide answers as ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... ... 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality of ... I focus on preventative care with all my patients to alleviate possible future issues. I ... free to contact my office and my trained staff will assist you in any way ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
Breaking Medicine Technology: